Search Results

You are looking at 1 - 10 of 13 items for :

  • endocrine factors x
  • Cardiovascular x
Clear All
Agata Hanna Bryk-Wiązania Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Agata Hanna Bryk-Wiązania in
Google Scholar
PubMed
Close
,
Mari Minasyan Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Mari Minasyan in
Google Scholar
PubMed
Close
,
Alicja Hubalewska-Dydejczyk Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Close
, and
Aleksandra Gilis-Januszewska Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
Department of Endocrinology, Oncological Endocrinology and Nuclear Medicine, University Hospital, Krakow, Poland

Search for other papers by Aleksandra Gilis-Januszewska in
Google Scholar
PubMed
Close

characteristics, corresponding to a prevalence of 3.2% ( 3 ). The postulated underlying mechanisms for increased risk involve: shortened activated partial thromboplastin time (aPTT), increased activity of factor VIII and von Willebrand factor, hyperactivity of

Open access
Shuang Wan Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China
Department of Endocrinology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China

Search for other papers by Shuang Wan in
Google Scholar
PubMed
Close
,
Chengcheng Zheng Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

Search for other papers by Chengcheng Zheng in
Google Scholar
PubMed
Close
,
Tao Chen Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

Search for other papers by Tao Chen in
Google Scholar
PubMed
Close
,
Lu Tan Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

Search for other papers by Lu Tan in
Google Scholar
PubMed
Close
,
Jia Tang Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

Search for other papers by Jia Tang in
Google Scholar
PubMed
Close
,
Haoming Tian Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

Search for other papers by Haoming Tian in
Google Scholar
PubMed
Close
, and
Yan Ren Adrenal Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China

Search for other papers by Yan Ren in
Google Scholar
PubMed
Close

, we aimed to compare their arrhythmia and heart rate variability (HRV) after correcting for confounding factors with PSM, clarify the impact of PA on the cardiac conduction system, and provide a factual basis for the early identification and prevention

Open access
Tao Gao Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China

Search for other papers by Tao Gao in
Google Scholar
PubMed
Close
,
Rui Liu Department of Oncology. The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China

Search for other papers by Rui Liu in
Google Scholar
PubMed
Close
,
Chunli Li Institute of Life Sciences, Chongqing Medical University, Chongqing, China

Search for other papers by Chunli Li in
Google Scholar
PubMed
Close
,
Xinglin Chu Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China

Search for other papers by Xinglin Chu in
Google Scholar
PubMed
Close
,
Qiao Guo Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China

Search for other papers by Qiao Guo in
Google Scholar
PubMed
Close
, and
Dazhi Ke Department of General Practice, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China

Search for other papers by Dazhi Ke in
Google Scholar
PubMed
Close

concentration of serum fetuin-B ( 6 ). At present, clinical studies have shown that fetuin-B may increase the risk of cardiovascular events ( 7 ). Lipid metabolism disorders and overweight are risk factors of hypertension. The researchers knocked down the FETUB

Open access
Simon Chang Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Internal Medicine, Lillebaelt Hospital, Kolding, Denmark

Search for other papers by Simon Chang in
Google Scholar
PubMed
Close
,
Arkadiusz J Goszczak NanoSYD, The Mads Clausen Institute, University of Southern Denmark, Sønderborg, Denmark

Search for other papers by Arkadiusz J Goszczak in
Google Scholar
PubMed
Close
,
Anne Skakkebæk Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anne Skakkebæk in
Google Scholar
PubMed
Close
,
Jens Fedder Centre of Andrology and Fertility Clinic, Odense University Hospital, Odense, Denmark

Search for other papers by Jens Fedder in
Google Scholar
PubMed
Close
,
Anders Bojesen Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Anders Bojesen in
Google Scholar
PubMed
Close
,
M Vakur Bor Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark

Search for other papers by M Vakur Bor in
Google Scholar
PubMed
Close
,
Moniek P M de Maat Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark
Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands

Search for other papers by Moniek P M de Maat in
Google Scholar
PubMed
Close
,
Claus H Gravholt Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Claus H Gravholt in
Google Scholar
PubMed
Close
, and
Anna-Marie B Münster Unit for Thrombosis Research, Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
Department of Clinical Biochemistry, Hospital of South West Jutland, Esbjerg, Denmark

Search for other papers by Anna-Marie B Münster in
Google Scholar
PubMed
Close

factor for VTE ( 7 ) and is capable of skewing the haemostatic balance ( 8 ). Thus, hypogonadism could be indirectly driving VTE risk in KS. We have recently presented data indicating that KS is not associated with a hypercoagulable state ( 9 ), while a

Open access
Charlotte Höybye Department of Endocrinology and Department of Molecular Medicine and Surgery, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden

Search for other papers by Charlotte Höybye in
Google Scholar
PubMed
Close
,
Beverly M K Biller Neuroendocrine Unit, Massachusetts General Hospital, Massachusetts General Hospital, Boston, Massachusetts, USA

Search for other papers by Beverly M K Biller in
Google Scholar
PubMed
Close
,
Jean-Marc Ferran Qualiance ApS, Copenhagen, Denmark

Search for other papers by Jean-Marc Ferran in
Google Scholar
PubMed
Close
,
Murray B Gordon Allegheny Neuroendocrinology Center, Division of Endocrinology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA

Search for other papers by Murray B Gordon in
Google Scholar
PubMed
Close
,
Nicky Kelepouris US Medical Affairs-Rare Endocrine Disorders, Novo Nordisk, Inc, Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Close
,
Navid Nedjatian Global Medical Affairs – Rare Endocrine Disorders, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Navid Nedjatian in
Google Scholar
PubMed
Close
,
Anne H Olsen Epidemiology, Novo Nordisk A/S, Soborg, Denmark

Search for other papers by Anne H Olsen in
Google Scholar
PubMed
Close
, and
Matthias M Weber Unit of Endocrinology, 1, Medical Department, University Hospital, Universitätsmedizin Mainz, der Johannes Gutenberg-Universität, Mainz, Germany

Search for other papers by Matthias M Weber in
Google Scholar
PubMed
Close

a negative impact on insulin sensitivity ( 13 ). Previously described models estimate the long-term probabilities for CV disease events based on the presence of CV risk factors, including cholesterol concentration, body mass index (BMI), systolic

Open access
Paweł Komarnicki Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Paweł Komarnicki in
Google Scholar
PubMed
Close
,
Paweł Gut Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Paweł Gut in
Google Scholar
PubMed
Close
,
Jan Musiałkiewicz Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Jan Musiałkiewicz in
Google Scholar
PubMed
Close
,
Maja Cieślewicz Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Maja Cieślewicz in
Google Scholar
PubMed
Close
,
Adam Maciejewski Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Adam Maciejewski in
Google Scholar
PubMed
Close
,
Prachi Patel Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Prachi Patel in
Google Scholar
PubMed
Close
,
George Mastorakos Unit of Endocrinology, Diabetes Mellitus and Metabolism, Aretaieion University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

Search for other papers by George Mastorakos in
Google Scholar
PubMed
Close
, and
Marek Ruchała Department of Endocrinology, Metabolism and Internal Diseases, Poznan University of Medical Sciences, Poznań, Poland

Search for other papers by Marek Ruchała in
Google Scholar
PubMed
Close

Introduction Neuroendocrine tumors (NETs) make up a heterogeneous group of neoplasms stemming from the diffuse endocrine system (DES) ( 1 ). Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a subdivision, most commonly

Open access
Alicia Romano Department of Pediatrics, New York Medical College, Valhalla, New York, USA

Search for other papers by Alicia Romano in
Google Scholar
PubMed
Close
,
Juan Pablo Kaski Centre for Inherited Cardiovascular Diseases, Great Ormond Street Hospital & UCL Institute of Cardiovascular Science, London, UK

Search for other papers by Juan Pablo Kaski in
Google Scholar
PubMed
Close
,
Jovanna Dahlgren Department of Paediatrics, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden

Search for other papers by Jovanna Dahlgren in
Google Scholar
PubMed
Close
,
Nicky Kelepouris US Medical Affairs, Novo Nordisk Inc., Plainsboro, New Jersey, USA

Search for other papers by Nicky Kelepouris in
Google Scholar
PubMed
Close
,
Alberto Pietropoli Global Medical Affairs, Novo Nordisk Health Care AG, Zurich, Switzerland

Search for other papers by Alberto Pietropoli in
Google Scholar
PubMed
Close
,
Tilman R Rohrer Department of Pediatric Endocrinology, University Children’s Hospital, Saarland University Medical Center, Homburg, Germany

Search for other papers by Tilman R Rohrer in
Google Scholar
PubMed
Close
, and
Michel Polak Paediatric Endocrinology, Diabetology and Gynaecology Department, Hôpital Universitaire Necker Enfants-Malades, AP-HP, Université de Paris, Imagine Institute, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed
Close

weight SDS were calculated using age- and gender-specific national references. GH, growth hormone; IGF1, insulin-like growth factor I; SDS, standard deviation score. The most common concomitant medications were CNS stimulants (12

Open access
Yumei Zhai The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Yumei Zhai in
Google Scholar
PubMed
Close
,
Haiming Fu Department of Clinical Laboratory, Baotou Maternal and Child Health Center, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Haiming Fu in
Google Scholar
PubMed
Close
,
Yu Li The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Yu Li in
Google Scholar
PubMed
Close
,
Siyuan Li The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Siyuan Li in
Google Scholar
PubMed
Close
,
Wenchen Zhang The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Wenchen Zhang in
Google Scholar
PubMed
Close
,
Jianwei Yue The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Jianwei Yue in
Google Scholar
PubMed
Close
, and
Zichao Wang The Second Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region, P.R. China

Search for other papers by Zichao Wang in
Google Scholar
PubMed
Close

crucial to mitigate associated disabilities and fatalities ( 5 ). Insulin resistance (IR) is a central factor in cardiovascular diseases ( 6 ). In hypertensive patients, IR not only exacerbates hypertension but also contributes to hypertension

Open access
Shenghe Luo College of Pharmacy, Yanbian University, Yanji, China

Search for other papers by Shenghe Luo in
Google Scholar
PubMed
Close
,
Yunhui Zuo Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China
Department of Cardiology, Yanbian University Hospital, Yanji, China

Search for other papers by Yunhui Zuo in
Google Scholar
PubMed
Close
,
Xiaotian Cui Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China

Search for other papers by Xiaotian Cui in
Google Scholar
PubMed
Close
,
Meiping Zhang Department of Cardiology, Yanbian University Hospital, Yanji, China

Search for other papers by Meiping Zhang in
Google Scholar
PubMed
Close
,
Honghua Jin Department of Pharmacy, Yanbian University Hospital, Yanji, China

Search for other papers by Honghua Jin in
Google Scholar
PubMed
Close
, and
Lan Hong Department of Physiology and Pathophysiology, College of Medicine, Yanbian University, Yanji, China

Search for other papers by Lan Hong in
Google Scholar
PubMed
Close

to diabetes and obesity ( 6 , 7 ). GLP-1R is located in the atria of the heart and can regulate the secretion of various hormones. Atrial natriuretic peptide (ANP) is a cardiac endocrine with a role in lowering blood pressure by regulating the

Open access
Mette Faurholdt Gude Medical/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Search for other papers by Mette Faurholdt Gude in
Google Scholar
PubMed
Close
,
Rikke Hjortebjerg Department of Molecular Endocrinology, University of Southern Denmark, Odense, Denmark
Steno Diabetes Centre Odense, Odense University Hospital, Odense, Denmark

Search for other papers by Rikke Hjortebjerg in
Google Scholar
PubMed
Close
,
Mette Bjerre Medical/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Search for other papers by Mette Bjerre in
Google Scholar
PubMed
Close
,
Morten Haaning Charles Department of Public Health, Aarhus University, Aarhus, Denmark
Steno Diabetes Centre Aarhus, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Morten Haaning Charles in
Google Scholar
PubMed
Close
,
Daniel R Witte Department of Public Health, Aarhus University, Aarhus, Denmark
Steno Diabetes Centre Aarhus, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Daniel R Witte in
Google Scholar
PubMed
Close
,
Annelli Sandbæk Department of Public Health, Aarhus University, Aarhus, Denmark
Steno Diabetes Centre Aarhus, Aarhus University Hospital, Aarhus, Denmark

Search for other papers by Annelli Sandbæk in
Google Scholar
PubMed
Close
, and
Jan Frystyk Endocrine Research Unit, Department of Endocrinology, Odense University Hospital & Department of Clinical Research, Faculty of Health, University of Southern Denmark, Odense, Denmark

Search for other papers by Jan Frystyk in
Google Scholar
PubMed
Close

likely related to its ability to increase insulin-like growth factor-1 (IGF1) action. PAPP-A activates IGF1 through proteolytic cleavage of IGF-binding proteins (IGFBP) -2, -4 and -5, which provides IGFBP fragments with low ligand affinity. By this

Open access